RSS

AMT

Article Date:  Mar 03 2009

AMT aspires to use its know-how and expertise in gene therapy to develop innovative treatments that significantly improve the lives of patients with serious, debilitating diseases.
AMT focuses on developing therapies for inherited diseases that affect small numbers of patients (orphan diseases). In addition, several of AMT’s programs allow us to target selected non-orphan diseases associated with serious morbidity and / or high mortality that can be treated with gene therapy.
AMT has a unique production platform that circumvents the obstacles that have hindered the development of drugs based on gene therapy technologies. Using adeno-associated viral vectors as the delivery vehicle of choice for therapeutic genes, the company has designed and validated a stable, scalable, commercially attractive and GMP-compliant AAV manufacturing platform.

This story is from Growth Company Investor, the independent voice on fast-growing companies. Subscribe today for the latest AIM recommendations.

Comments 

There are currently no comments on this article

Sign up and get...

  • Regular GrowthBusiness newsletters
  • Post comments on articles
Sign up

Research

  • Directors' Pay AIM 2009

    What should an AIM company pay its CEO or FD?
    What should a non-executive director or chairman expect to be paid?
    What benchmarks should AIM remuneration committee members be using when
    setting pay?

VCT Special Report 2009

This reports principle aim is to provide business owners seeking funding with information about the amount of funds that VCTs have to invest.

Cash Shells Special Report 2009

A comprehensive overview of cash shells on AIM and PLUS, companies that have become a significant feature on the market landscape.

More

Events Calendar

The Media Magnate Awards 2009

26th March, Vinopolis, London

More

More News: Small-Cap Spotlight

Resource Trust seeks £70m

Specialist resources investor Baker Steel Capital Managers plans to float a trust to make pre-flotation investments in the sector.

Terrace Hill moots fund launch

Property group Terrace Hill is 'actively considering' launching a residential fund after trimming annual losses to £27 million.

Strong orders at Mears Group

Social housing specialist Mears Group cites a strong order pipeline after increasing annual pre-tax profits 11 per cent to £18.4 million. 

Advertisement

Related articles

to-BBB

Shore Capital

Poll

Which currency will gain most this year?





Have your vote on current issues

People who read this also read

White Papers

12 Key Points to Consider When Selecting a Network Scanning Solution

Discover the 12 key points your company should consider before you evaluate and select a vulnerability assessment solution.

15-Minute Guide to Collaborative Case Management

This particular guide focuses on an innovative approach to case management in the public sector - Collaborative Case Management (CCM).

15-Minute Guide to Intelligent Capture

Intelligent capture enables organizations to cope with enormous volumes and varieties of documents, accelerate information time to value, and reduce the IT burden of supporting multiple point solutions.

More